Delivery Order SPE2DX15D8002-SPE2DX24F2WT2
Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $9.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $3,287.55 and a period of performance extending through March 13, 2025. Dakota Drug, Inc. is a key supplier for the DLA's medical supply chain, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Trulicity 1.5 mg/0.5 ml pens. The $2,505.06 contract has a performance period through July 31, 2024 and does not have a set-aside designation. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in the System for Award Management (SAM.gov). The $13,783.74 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a performance period through November 19, 2024 and was awarded on November 18, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The $2,888.62 contract is for the provision of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of September 12, 2024. Dakota Drug, Inc. has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,174.51 and a completion date of September 26, 2023. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,579.40, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This contract is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Trulicity 0.75 mg/0.5 ml pens. The $2,952.18 firm fixed-price contract has a period of performance through February 26, 2025. Dakota Drug, Inc. holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to deliver a range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,502.05, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. It is a firm fixed-price contract with a performance period ending on March 5, 2024. Dakota Drug, Inc. is a key supplier for the DLA's medical supply chain, holding a significant single-award Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,258.70, is for the delivery of Trulicity 0.75 mg/0.5 ml insulin pens to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a...
- This is a $2,225.67 firm fixed price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract was awarded by the Defense Logistics Agency (DLA) for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA Troop Support Medical's ECAT Generation V Program, which...
- SPE2DX15D8002Indefinite Delivery Contract
- SPE2DX15D8002-SPE2DX24F2WT2Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity insulin pens. The $9,900.35 firm fixed price contract has a performance period through June 18, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the DLA's Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA's ECAT Generation V Program. This contract award is not set aside and allows Dakota Drug, Inc. to efficiently deliver critical medical items to various defense healthcare facilities to support U.S. Armed Forces medical operations.
Generated 5/17/25, 10:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 6/17/24 |